跳转至内容
Merck
所有图片(1)

Key Documents

View All Documentation

194824

Sigma-Aldrich

硼烷二甲基硫醚络合物 溶液

2.0 M in toluene

别名:

BMS, 三氢 [硫代双 [甲烷]] 硼

登录查看公司和协议定价
所有图片(1)

About This Item

线性分子式:
(CH3)2S · BH3
CAS号:
13292-87-0
分子量:
75.97
Beilstein:
3663489
MDL號碼:
MFCD00013189
分類程式碼代碼:
12352112
PubChem物質ID:
24851335

反應適用性

reagent type: reductant

濃度

2.0 M in toluene

密度

0.856 g/mL at 25 °C

SMILES 字串

B.CSC

InChI

1S/C2H6S.BH3/c1-3-2;/h1-2H3;1H3

InChI 密鑰

RMHDLBZYPISZOI-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

應用

用作区域选择性还原剂的反应物

涉及的反应物：
  • 硼氢化/氧化
笼状化合物的合成

訊號詞

Danger

危險分類

Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Aquatic Chronic 3 - Asp. Tox. 1 - Eye Dam. 1 - Flam. Liq. 2 - Repr. 1B - Skin Irrit. 2 - STOT RE 2 - STOT SE 3 - Water-react 1

標靶器官

Central nervous system

安全危害

EUH014

儲存類別代碼

4.3 - Hazardous materials which set free flammable gases upon contact with water

水污染物質分類（WGK）

WGK 3

閃點（°F）

44.6 °F - closed cup

閃點（°C）

7 °C - closed cup

個人防護裝備

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

从最新的版本中选择一种：

分析证书(COA)

Lot/Batch Number
61496TM
09996HJ
S46238
04806TH
S44928

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Saskia Ditisheim et al.
Inflammatory bowel diseases, 21(11), 2598-2604 (2015-08-06)
Inflammatory bowel diseases (IBD) are systemic conditions that commonly display extraintestinal manifestations. Inflammatory articular disease (IAD: axial or peripheral) is the most common extraintestinal manifestation. The aim of this study was to evaluate the prevalence and the clinical characteristics associated
Veena K Ranganath et al.
Arthritis care & research, 67(7), 929-939 (2015-01-13)
To evaluate the effect of sustained American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) Boolean remission on residual joint inflammation assessed by magnetic resonance imaging (MRI) and to secondarily evaluate other clinical definitions of remission, within an early seropositive
Isidoro González-Álvaro et al.
Rheumatology (Oxford, England), 54(7), 1200-1209 (2014-12-21)
The aim of this study was to establish guidelines for the optimization of biologic therapies for health professionals involved in the management of patients with RA, AS and PsA. Recommendations were established via consensus by a panel of experts in
Elin S Gray et al.
Oncotarget, 6(39), 42008-42018 (2015-11-03)
Repeat tumor biopsies to study genomic changes during therapy are difficult, invasive and data are confounded by tumoral heterogeneity. The analysis of circulating tumor DNA (ctDNA) can provide a non-invasive approach to assess prognosis and the genetic evolution of tumors
Jeong Won Jang et al.
Hepatology (Baltimore, Md.), 61(6), 1809-1820 (2015-01-30)
The effect of viral suppression on long-term disease outcome after decompensation in patients with hepatitis B virus (HBV)-related cirrhosis has not been established. The aim of this study was to determine the long-term effect of antiviral therapy (AVT) in patients
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门